Table:
begin	end	state
1	19	cytoplasmic
20	36	transmembrane
37	55	non-cytoplasmic
56	79	transmembrane
80	88	cytoplasmic
89	130	transmembrane
131	156	cytoplasmic
157	177	transmembrane
178	183	non-cytoplasmic
184	203	transmembrane
204	257	cytoplasmic
258	280	transmembrane
281	294	non-cytoplasmic
295	320	transmembrane
321	331	cytoplasmic
332	350	transmembrane
351	355	non-cytoplasmic
356	378	transmembrane
379	385	cytoplasmic
386	412	transmembrane
413	417	non-cytoplasmic
418	439	transmembrane
440	451	cytoplasmic

Input:
>RR42_RS29085 FitnessBrowser__Cup4G11:RR42_RS29085
MNLSNTINVAGEATRRSHVRYWILLMIFVVTTVNYADRATLSITGPAMRSEFGFDAVQMG
FIFSAFSWAYVMAQIPGGWLLDRFGARRIYACSIFLWSFFTLLQGFIGVFATVGAAVTTL
FVLRFAVGLAESPAFPANAKVVASWFPTAERGTASAIFNSAQYFAAVLFTPLMAWLTHAL
GWHHVYLWMGALGMVLAGLWLKVVRSPATHPGVNRAELDYIKQGGGLIEMSGDAGKKDKE
ASGTRWFYVRQLLSNRMLLGVYLGQYCINVLTYFFLTWFPVYLVQARGMSILKAGFVASL
PAICGFLGGVLGGVISDGFLRRGYSLTVARKVPIVAGMLLSVSMIACNYVDSEWLVVGFM
ALAFFGKGIGALGWAVVADTAPKEVIGLAGSIFNMFGNIAGIVTPIVIGYILGTTGSFNG
ALVFVGANALVTVISYLVIVKEIKRVELKHP

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server